Woman’s Rare Diagnosis Prompts Sweeping Treatment to Target Cysts

HIPEC, a procedure that combines surgery and heated chemotherapy, gave one patient peace of mind after hundreds of cysts were removed from her abdomen.

7:00 AM

Author | Nicole Fawcett

Melissa Hough considers herself to be patient No. 154. That's how unusual her condition is.

In June, she was diagnosed with cystic mesothelioma. It's a noncancerous version of the lung disease commonly linked to asbestos exposure. In Hough's case, hundreds of cysts had developed throughout her abdomen.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

"When I first heard 'mesothelioma,' I freaked out," says Hough, 52. "But then I did research online and talked to my doctor. That was the first time I actually had some relief.

"I had spent six months with an unnerving feeling wondering what's going on in my body. It was a relief to know what it was."

While the cysts were not cancer, they are known to come back after surgery about half the time. And if left untreated, the cysts would grow and accumulate inside the belly, causing intestinal blockage or breathing issues. They could eventually become cancer.

Meanwhile, the cysts were causing Hough significant pain.

She knew surgery was necessary. She also knew it would be extensive, stretching from her rib cage to her pelvic bone. She was prepared.

What her surgeon suggested next was less expected.

Treating a 'mystical' diagnosis

Clifford Cho, M.D., chief of hepatopancreatobiliary and advanced gastrointestinal surgery at Michigan Medicine, recommended a new procedure called hyperthermic intraperitoneal chemotherapy, or HIPEC.

It would involve the expected open surgery, in which Cho would remove as many cysts as he could.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

But then, the surgical team would bathe Hough's abdomen in a warm vat of chemotherapy to kill any remaining diseased cells.

"Melissa's diagnosis is so rare, it's almost mystical," Cho says. "There are very few papers written about it and no clear consensus on what the best treatment is."

HIPEC was a good option because surgery alone would not be enough. "Because the cysts are so diffuse, the likelihood of getting all microscopic cells is preposterous," Cho says.

Adding the chemotherapy maximizes the chance of getting all those cells as the drug comes in direct contact with all the nooks and crannies throughout the abdominal cavity.

Hough was initially shocked at the severity of the treatment but says Cho's explanations quickly put her at ease.

"My eyes got really big, thinking 'what are you doing? This is science fiction!' But then I knew I had a plan — I know what it is and I know what's going to happen," says Hough, a project manager at a technology company.

Our big motivation was to consider if there's something we can do now to minimize the chances of this disease impacting her when she's older.
Clifford Cho, M.D.

Finding certainty

It took her a long time to get to that point.

Her mother had died of intestinal cancer but it was thought to have originated as ovarian cancer. Hough had a history of painful ovarian cysts, which resulted in a full hysterectomy and removal of her ovaries, in 2014.

SEE ALSO: Ovarian Cancer Symptoms and Risk Factors to Know [Infographic]

So when it felt like another ovarian cyst was developing, she worried about ovarian conditions, especially ovarian remnant syndrome, a rare condition in which ovarian tissue is left behind after oophorectomy.

For six months, Hough sought answers.

She went to an oncologist who told her she had gas. She met with a surgeon who ran multiple tests but couldn't determine her diagnosis. Finally, he removed her gall bladder, and it was during that operation when he saw hundreds of cysts throughout her abdomen.

Hough came to Michigan Medicine, where Cho was familiar with her diagnosis, the controversies about it and the potential treatment options.

"The only thing worse than the fear these rare diagnoses cause is the uncertainty," Cho says. "Patients have literally thousands of questions about their diagnosis, and that's compounded in people who have really rare diagnoses."

A strong recovery

Hough's motivation, mixed with her young age, helped her get through the HIPEC procedure with minimal side effects.

Because the chemotherapy doesn't enter the bloodstream, it did not cause any of the traditional chemotherapy side effects, such as nausea and hair loss.

It's a long recovery, though. The first five days she says were especially difficult.

She came out of the lengthy operation with a nasal gastric tube, which was there to suction the bile from her stomach while her organs healed from the procedure. Once the tube came out, she quickly felt better and was back home in Holt, Michigan, one week after the procedure.

Hough continues to recover and recently returned to work. Her biggest challenge was fatigue: A long phone call or visit would leave her tired, and while her job is not physical, she knew the mental work of managing technology installation processes would be too much.

One comfort is Clover, her 6-year-old greyhound-Irish wolfhound whom she adopted as a puppy. Hough has adopted three retired racing greyhounds before Clover, dating back to 1999. She also volunteers with Greyhound Expressions, a greyhound adoption group.

"They're awesome dogs," she says about the breed.

Positive path forward

As she continues to recover, Hough will see Cho regularly for scans to check for signs of cysts returning. But Cho thinks the aggressive treatment now gives her the best chance for the future.

SEE ALSO: Collecting a Family's Cancer History: What You Should Ask

"She's young and healthy," Cho says. "Our big motivation was to consider if there's something we can do now to minimize the chances of this disease impacting her when she's older."

Hough knew the approach was extreme, but she also felt it was the right choice.

"If this is what works for an aggressive form of cancer, it should work for the benign cells," she says. "I was motivated and went in with a good attitude. I think that made a difference."

Photo by Leisa Thompson


More Articles About: Cancer Care Rogel Cancer Center Chemotherapy Abdominal Surgery Hospitals & Centers
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Blurred image of health care professionals in blue scrubs pushing a gurney down a hallway
Health Lab
Primary care scarcity linked to more surgical emergencies, problems
Patients living in areas with the worst shortages of primary care providers are more likely to have emergency surgery, surgical complications and hospital readmissions.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants
Julie
Philanthropy News
A Family’s Cancer Journey and Loss Inspire an Oncology Nursing Excellence Award
Julie was a master gardener who grew up on a fruit farm in southwest Michigan. She also had a family history of cancer, which sadly foreshadowed her own ovarian cancer diagnosis.
Gloved hands holding silicone chips used in cancer research
Health Lab
Is lung cancer treatment working? This chip can tell from a blood draw
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.
art work with flower circle green teal orange yellow pink on display
Health Lab
Quiet strength of nature heals those dealing with cancer
An art exhibition explores the physical and emotional complexities of the cancer journey by combining anatomy with nature.